These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2339632)

  • 1. Fluoride-induced fractures: relation to osteogenic effect.
    Bayley TA; Harrison JE; Murray TM; Josse RG; Sturtridge W; Pritzker KP; Strauss A; Vieth R; Goodwin S
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S217-22. PubMed ID: 2339632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous hip fractures in fluoride-treated patients: potential causative factors.
    Gutteridge DH; Price RI; Kent GN; Prince RL; Michell PA
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S205-15. PubMed ID: 2339631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response.
    Murray TM; Harrison JE; Bayley TA; Josse RG; Sturtridge WC; Chow R; Budden F; Laurier L; Pritzker KP; Kandel R
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S27-35. PubMed ID: 2339633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term treatment of steroid osteoporosis with fluoride.
    Bayley TA; Muller C; Harrison J; Basualdo J; Sturtridge W; Josse R; Murray TM; Pritzker KP; Vieth R; Goodwin S
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S157-61. PubMed ID: 2339626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
    Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
    J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress fractures of the lower limbs in osteoporotic patients treated with fluoride.
    Orcel P; de Vernejoul MC; Prier A; Miravet L; Kuntz D; Kaplan G
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S191-4. PubMed ID: 2339628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
    Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
    Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
    N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for the development of stress fractures during fluoride therapy for osteoporosis.
    Schnitzler CM; Wing JR; Mesquita JM; Gear AK; Robson HJ; Smyth AE
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S195-200. PubMed ID: 2339629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
    Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis.
    Harrison JE; Bayley TA; Josse RG; Murray TM; Sturtridge W; Williams C; Goodwin S; Tam C; Fornasier V
    Bone Miner; 1986 Sep; 1(4):321-33. PubMed ID: 3504712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements.
    Nagant de Deuxchaisnes C; Devogelaer JP; Depresseux G; Malghem J; Maldague B
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S5-26. PubMed ID: 2187327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoride therapy of type I osteoporosis.
    Devogelaer JP; Nagant de Deuxchaisnes C
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():26-31. PubMed ID: 8846658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium fluoride therapy of postmenopausal osteoporosis.
    Kleerekoper M; Mendlovic DB
    Endocr Rev; 1993 Jun; 14(3):312-23. PubMed ID: 8319597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.
    Pak CY; Sakhaee K; Adams-Huet B; Piziak V; Peterson RD; Poindexter JR
    Ann Intern Med; 1995 Sep; 123(6):401-8. PubMed ID: 7639438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years].
    Pouillès JM; Trémollières F; Ribot C
    Rev Rhum Mal Osteoartic; 1992 Feb; 59(2):103-13. PubMed ID: 1604221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
    Pak CY; Sakhaee K; Zerwekh JE; Parcel C; Peterson R; Johnson K
    J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iliac bone biopsies at the time of periarticular stress fractures during fluoride therapy: comparison with pretreatment biopsies.
    Schnitzler CM; Mesquita JM; Gear KA; Robson HJ; Moodley GP; Smyth AE
    J Bone Miner Res; 1990 Feb; 5(2):141-52. PubMed ID: 2316402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The causes of bone scintigram hot spots in fluoride-treated osteoporotic patients.
    Schulz EE; Flowers C; Sauser DD; Brin BN; Wergedal JE; Baylink DJ
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S201-4. PubMed ID: 2339630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.